NCT02262546View on ClinicalTrials.gov

Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

October 31, 2007

Conditions
Healthy
Interventions
DRUG

Pramipexole extended-release (ER) tablets

DRUG

Pramipexole immediate-release (IR) tablets

DRUG

Moxifloxacin

DRUG

Pramipexole Placebo

DRUG

Moxifloxacin Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02262546 - Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter